ArticleScientific reports2025
Nano-chitosan-coated, green-synthesized selenium nanoparticles as a novel antifungal agent against Sclerotinia sclerotiorum: in vitro study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Nano-enabled spray-induced RNA interference against fungal pathogens of oilseed crops: carrier performance, delivery evidence and field translation.World journal of microbiology & biotechnology · 2026Review
- Silica based ZnFeScientific reports · 2026Article
- Harnessing Nanoparticles and Nanosuspensions to Combat Powdery Mildew: A Frontier in Vegetable and Fruit Protection.Journal of fungi (Basel, Switzerland) · 2025Review
- Bioeconomy-Based Approaches for the Microbial Valorization of Citrus Processing Waste.Microorganisms · 2025Review
- Antifungal and biodegradable nanoencapsulation ofFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemical fungicides have been used to control fungal diseases like Sclerotinia sclerotiorum. These fungicides must be restricted because of their toxicity and the development of resistance strains. Therefore, utilizing natural nanoscale materials in agricultural production is a potential alternative. This work aimed to investigate the antifungal properties of a nanocomposite (nano-chitosan-coated, green-synthesized selenium nanoparticles) against the plant pathogenic fungus S. sclerotiorum. Chemical reduction was used to produce selenium nanoparticles from citrus peel extracts, and ionotropic gelation was used to produce chitosan nanoparticles. The nanocomposite has been produced using selenium nanoparticles stabilized by chitosan and cross-linked with sodium tripolyphosphate. Transmission electron microscopy, dynamic light scattering, X-ray diffraction, UV-VIS spectroscopy, and Fourier transform infrared spectroscopy were used to characterize all produced nanostructures. The in vitro antifungal activity and minimum inhibitory concentration of all bulk and nanostructures are investigated at (0.5, 1, 5, 10, 50, 100) ppm concentrations. Scanning electron microscopy was used to detect structural deformations in the fungal mycelium. The findings support the successful synthesis and characterization of all nanoparticles. Lemon peel extract produced smaller, more stable, and distributed selenium nanoparticles (42.28 ± 18.5 nm) than orange peel extract (85.7 ± 140.22 nm). Nanostructures, particularly nanocomposite, have shown a considerable increase in antifungal efficacy compared to bulk structures. At a minimum inhibitory concentration of 0.5 ppm, the nanocomposite exhibited 100% inhibitory activity. The nanocomposite with a concentration of 0.5 ppm exhibited the lowest average fungal biomass (0.32 ± 0.05 g) among all tested nanostructures. Fungal hyphae treated with 0.5 ppm of nanocomposite within 18 h of treatment revealed substantial damage and deformation. These results provide new insights into the nanocomposite as an eco-friendly and promising antifungal agent against other plant pathogenic fungi.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.